Literature DB >> 15474664

Gender difference in human papillomarvirus infection for non-small cell lung cancer in Taiwan.

Ya-Wen Cheng1, Hui-Ling Chiou, Jung-Ta Chen, Ming-Chih Chou, Torng-Sen Lin, Wu-Wei Lai, Chih-Yi Chen, Yi-Yu Tsai, Huei Lee.   

Abstract

Our previous reports have indicated that high risk human papillomarvirus (HPV) 16/18 were much more frequently detected in lung tumors of female patients as compared to that of male patients and HPV 16/18 in lung tumors were evolutionally correlated with those in blood circulation. In the other hand, it is well known that HPV 6/11 are frequently associated with upper aerodigestive and respiratory diseases. HPV 6/11 DNA were detected in lung tumors by nested PCR and in situ hybridization to investigate if any difference in prevalent types of HPV exists between genders. Our data showed that HPV 6 infection was detected in 28.4% (40 of 141) lung tumors, which was significantly higher than that in non-cancer controls (1.7%, 1 of 60; P < 0.0001), however, such high prevalence was not observed for HPV 11. Among studied clinico-pathological parameters, HPV 6 infection was significantly related with gender (P = 0.002) and smoking status (P = 0.014). After being stratified by gender and smoking status, HPV 6 infection rate in lung tumors of non-smoking male patients was much higher than that in non-smoking female patients (33.3% versus 11.1%; P = 0.023), but no difference between smoking and non-smoking male patients (38.1% versus 33.3%). With adjustments for age, tumor type, and tumor stage, smoking male lung cancer patients had a much higher OR value (OR, 7.35; 95%CI, 2.11-25.58) for HPV 6 infection compared with 3.93 (95% CI, 1.17-13.12) of non-smoking male patients. Moreover, a higher prevalence of HPV 6 was detected in lung tumors of smoking male patients with early tumor stage than those with advanced stages (P = 0.008), but not in non-smoking male and female patients. A higher prevalence of HPV 6 in male lung cancer patients, as compared with female lung cancer patients, indicating not only different HPV infection routes for different genders, but also that HPV 6 infections may act as a prospective early risk marker of lung cancer for smoking male patients in Taiwan.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474664     DOI: 10.1016/j.lungcan.2004.03.023

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  17 in total

Review 1.  Lung cancer in never smokers: clinical epidemiology and environmental risk factors.

Authors:  Jonathan M Samet; Erika Avila-Tang; Paolo Boffetta; Lindsay M Hannan; Susan Olivo-Marston; Michael J Thun; Charles M Rudin
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

2.  Detection and genotype analysis of human papillomavirus in non-small cell lung cancer patients.

Authors:  Emmanouela Sarchianaki; Stavros P Derdas; Markos Ntaoukakis; Elena Vakonaki; Eleni D Lagoudaki; Ismini Lasithiotaki; Anna Sarchianaki; Anastasios Koutsopoulos; Emmanouil K Symvoulakis; Demetrios A Spandidos; Katerina M Antoniou; George Sourvinos
Journal:  Tumour Biol       Date:  2013-12-06

Review 3.  Lung cancer in never smokers.

Authors:  Ping Yang
Journal:  Semin Respir Crit Care Med       Date:  2011-04-15       Impact factor: 3.119

4.  Correlation between squamous cell carcinoma of the lung and human papillomavirus infection and the relationship to expression of p53 and p16.

Authors:  Xiaohong Fan; Keke Yu; Jie Wu; Jinchen Shao; Lei Zhu; Jie Zhang
Journal:  Tumour Biol       Date:  2014-12-28

Review 5.  It's all about sex: gender, lung development and lung disease.

Authors:  Michelle A Carey; Jeffrey W Card; James W Voltz; Samuel J Arbes; Dori R Germolec; Kenneth S Korach; Darryl C Zeldin
Journal:  Trends Endocrinol Metab       Date:  2007-08-30       Impact factor: 12.015

6.  HPV-associated lung cancers: an international pooled analysis.

Authors:  Camille Ragin; Monisola Obikoya-Malomo; Sungjin Kim; Zhengjia Chen; Rafael Flores-Obando; Denise Gibbs; Chihaya Koriyama; Francisco Aguayo; Jill Koshiol; Neil E Caporaso; Giovanna E Carpagnano; Marco Ciotti; Hirotoshi Dosaka-Akita; Masashi Fukayama; Akiteru Goto; Demetrios A Spandidos; Vassilis Gorgoulis; Daniëlle A M Heideman; Robert A A van Boerdonk; Kenzo Hiroshima; Reika Iwakawa; Nikolaos G Kastrinakis; Ichiro Kinoshita; Suminori Akiba; Maria T Landi; H Eugene Liu; Jinn-Li Wang; Ranee Mehra; Fadlo R Khuri; Wan-Teck Lim; Taofeek K Owonikoko; Suresh Ramalingam; Emmanuela Sarchianaki; Kari Syrjanen; Ming-Sound Tsao; Jenna Sykes; Siew Wan Hee; Jun Yokota; Apostolos Zaravinos; Emanuela Taioli
Journal:  Carcinogenesis       Date:  2014-02-12       Impact factor: 4.944

7.  Human papillomavirus-16 presence and physical status in lung carcinomas from Asia.

Authors:  Francisco Aguayo; Muhammad Anwar; Chihaya Koriyama; Andres Castillo; Quanfu Sun; Jacob Morewaya; Yoshito Eizuru; Suminori Akiba
Journal:  Infect Agent Cancer       Date:  2010-11-16       Impact factor: 2.965

8.  Human papillomavirus type 16 and 18 in primary lung cancers--a meta-analysis.

Authors:  Malini Srinivasan; Emanuela Taioli; Camille C Ragin
Journal:  Carcinogenesis       Date:  2009-07-20       Impact factor: 4.944

9.  Urinary metabolites of a polycyclic aromatic hydrocarbon and volatile organic compounds in relation to lung cancer development in lifelong never smokers in the Shanghai Cohort Study.

Authors:  Jian-Min Yuan; Lesley M Butler; Yu-Tang Gao; Sharon E Murphy; Steven G Carmella; Renwei Wang; Heather H Nelson; Stephen S Hecht
Journal:  Carcinogenesis       Date:  2013-10-22       Impact factor: 4.944

10.  Identification of Key Genes and Pathways in Gefitinib-Resistant Lung Adenocarcinoma using Bioinformatics Analysis.

Authors:  Kailin Mao; Fang Lin; Yingai Zhang; Hailong Zhou
Journal:  Evol Bioinform Online       Date:  2021-06-11       Impact factor: 1.625

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.